These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9760694)

  • 1. Orally active nonpeptide CCK-A agonists.
    Sugg EE; Birkemo L; Gan LS; Tippin TK
    Pharm Biotechnol; 1998; 11():507-24. PubMed ID: 9760694
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of gastric emptying by bombesin-like peptides is dependent upon cholecystokinin-A receptor activation.
    Ladenheim EE; Wohn A; White WO; Schwartz GJ; Moran TH
    Regul Pept; 1999 Oct; 84(1-3):101-6. PubMed ID: 10535415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.
    Bignon E; Alonso R; Arnone M; Boigegrain R; Brodin R; Gueudet C; Héaulme M; Keane P; Landi M; Molimard JC; Olliero D; Poncelet M; Seban E; Simiand J; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):752-61. PubMed ID: 10215649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C; Kisfalvi I; D'Amato M; Varga G
    Aliment Pharmacol Ther; 1996 Jun; 10(3):411-9. PubMed ID: 8791971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
    Henke BR; Aquino CJ; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; Hirst GC; James MK; Johnson MF; Queen KL; Sherrill RG; Sugg EE; Suh EM; Szewczyk JW; Unwalla RJ; Yingling J; Willson TM
    J Med Chem; 1997 Aug; 40(17):2706-25. PubMed ID: 9276016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
    de Tullio P; Delarge J; Pirotte B
    Curr Med Chem; 1999 Jun; 6(6):433-55. PubMed ID: 10213792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the chemical structure of peptides as the starting point to design nonpeptide agonists and antagonists at peptide receptors: examples with cholecystokinin and tachykinins.
    Horwell DC
    Bioorg Med Chem; 1996 Oct; 4(10):1573-6. PubMed ID: 8931926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
    Oliver AS; Vigna SR
    Gen Comp Endocrinol; 1997 Jan; 105(1):91-101. PubMed ID: 9000471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.
    Hirst GC; Aquino C; Birkemo L; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Henke B; James MK; Johnson MF; Momtahen T; Queen KL; Sherrill RG; Szewczyk J; Willson TM; Sugg EE
    J Med Chem; 1996 Dec; 39(26):5236-45. PubMed ID: 8978852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostriatal neurons of rats can be influenced by cholecystokinin-A receptor agonists.
    Davidowa H; Wetzel K; Henklein P
    Neuropeptides; 1997 Jun; 31(3):231-5. PubMed ID: 9243519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefaclor, a cephalosporin antibiotic, delays gastric emptying rate by a CCK-A receptor-mediated mechanism in the rat.
    Bozkurt A; Deniz M; Yegen BC
    Br J Pharmacol; 2000 Oct; 131(3):399-404. PubMed ID: 11015288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans.
    Kreiss C; Schwizer W; Borovicka J; Jansen JB; Bouloux C; Pignol R; Bischof Delaloye A; Fried M
    Regul Pept; 1998 Jun; 74(2-3):143-9. PubMed ID: 9712175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents.
    Pierson ME; Comstock JM; Simmons RD; Kaiser F; Julien R; Zongrone J; Rosamond JD
    J Med Chem; 1997 Dec; 40(26):4302-7. PubMed ID: 9435899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists.
    Fourmy D; Escrieut C; Archer E; Galès C; Gigoux V; Maigret B; Moroder L; Silvente-Poirot S; Martinez J; Fehrentz JA; Pradayrol L
    Pharmacol Toxicol; 2002 Dec; 91(6):313-20. PubMed ID: 12688374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.
    Miller LJ; Desai AJ
    Trends Endocrinol Metab; 2016 Sep; 27(9):609-619. PubMed ID: 27156041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soybean beta-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats.
    Nishi T; Hara H; Tomita F
    J Nutr; 2003 Feb; 133(2):352-7. PubMed ID: 12566466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
    Wu CL; Doong ML; Wang PS
    Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.